Soft Tissue Sarcoma of the Trunk and Extremities
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma of the Trunk and Extremities.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas [Phase 3]
This Phase 3 trial is evaluating whether adding immunotherapy to chemotherapy improves outcomes versus chemotherapy alone in patients with a…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating adding abemaciclib to gemcitabine for soft tissue sarcoma; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities [Phase 2]
Phase 2 clinical trial evaluating whether limited versus intense postoperative surveillance affects patient-reported outcomes in patients wi…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma [Phase 2]
Phase 2 study evaluating cemiplimab in combination with palbociclib for advanced or unresectable dedifferentiated liposarcoma; the trial is …